Healthcare - Biotechnology - NASDAQ - US
$ 0.8284
-18 %
$ 45.7 M
Market Cap
-0.58
P/E
INCOME STATEMENT
3.09 M
REVENUE
-100 M
OPERATING INCOME
-97.4 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Omega Therapeutics, Inc.
| Revenue | 3.09 M |
| Cost Of Revenue | 65.9 M |
| Gross Profit | -62.8 M |
| Operating Expenses | 103 M |
| Operating Income | -100 M |
| Other Expenses | -2.83 M |
| Net Income | -97.4 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 3.1 | 2.1 | 0.1 | 0 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 65.9 | 5.2 | 1.4 | 1.1 | 0.8 |
| Gross Profit | (62.8) | (3.1) | (1.2) | (1.1) | (0.8) |
| OPERATING INCOME | |||||
| Operating Expenses | 103.4 | 104.8 | 66.2 | 28.6 | 17.3 |
| Selling, General and Administrative Expenses | 26.2 | 21.8 | 16.6 | 6.2 | 4.2 |
| Research and Development Expenses | 77.2 | 80.0 | 47.9 | 21.1 | 11.9 |
| Operating Income | (100.3) | (102.8) | (66.0) | (28.6) | (17.3) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 0 | 0.2 | 0.9 | 0.8 | 0.6 |
| Total Other Income | 2.8 | 65 K | (2.2) | (0.8) | (0.6) |
| Pre-Tax Income | (97.4) | (102.7) | (68.3) | (29.4) | (17.9) |
| NET INCOME | |||||
| Tax Provision | 0 | 65 K | 0.9 | 0.8 | 0.6 |
| Net Income | (97.4) | (102.6) | (69.2) | (30.2) | (18.5) |
| EPS | 1.8 | 2.14 | 1.45 | 0.63 | 0.39 |